This is a recording of the January 29, 2026 Wellspring discussion with Dr. Maureen McCall. Dr. Maureen McCall has been a family physician for 37 years, practising in Kingston, Ontario and Red Deer, Alberta. Her medical training started at the University of Alberta, and included a family medicine residency at Queen's University, and a master's degree in Public Health at Harvard University.

Maureen has been a board member and Red Deer volunteer for Wellspring Alberta for nearly 4 years.

Wellspring is a Canada-wide network of charities, offering programs and services, at no charge and without referral, to anyone, with any type of cancer, at any stage in their journey.

Wellspring Alberta's website: https://wellspringalberta.ca/

Wellspring Canada's website: https://wellspring.ca/

If you have any questions or comments about this video, please contact us.

[Watch on YouTube]

Have you or a loved one been treated with TIBSOVO® (ivosidenib)?

Patient organizations are gathering input from patients and caregivers to inform a funding review of TIBSOVO® in Canada for people with locally advanced or metastatic cholangiocarcinoma (bile duct cancer) with an IDH1 mutation.

We invite individuals who have experienced treatment with TIBSOVO®, including caregivers, to participate in a confidential 45-minute telephone interview focused on cancer care and treatment experience. Insights shared will help inform access decisions for this therapy.

To learn more or take part, please contact Brenda Clayton at tibsovo@mychcc.ca or phone 1-877-694-0314 (toll-free).

[CHCC's Contact Page]

[Newswire.ca] Patient Organizations Welcome Approval of Six Life-Extending Cancer Treatments Through Ontario's FAST Program, Urge National Expansion
Leading patient organizations are welcoming Ontario's announcement that six cancer drugs are now being fast-tracked for public funding through the province's Funding Accelerated for Specific Treatments (FAST) program, calling it an important step forward for cancer patients and a model other provinces and territories should follow.

The Colorectal Cancer Resource & Action Network (CCRAN), in collaboration with a coalition of national patient organizations, applauds Ontario's leadership in accelerating access to life-extending cancer treatments, enabling patients to receive promising therapies sooner and reducing the lengthy delays that have long characterized public drug funding in Canada.

[Read the full article]

CHCC and Dr. Maureen McCall are hosting a Zoom webinar to discuss Wellspring and the services they offer to cancer patients in Canada. The webinar will be held January 29, 2026 @ Noon ET / 10AM MT.

[Register for Dr. Maureen McCall's Webinar]

This is a recording of the January 14, 2026 presentation entitled, "Precision in Practice: Modeling the Costs & Benefits of Comprehensive Genomic Profiling for Five Stage 4 Cancers in Canada" by Filomena Servidio-Italiano, President & CEO of the Colorectal Cancer Resource & Action Network (CCRAN).

The Colorectal Cancer Resource & Action Network (CCRAN) is a national, patient-focused advocacy group championing the health and wellbeing of Canadians touched by colorectal cancer and others at risk of developing the disease. CCRAN provides support, education, and advocacy to patients (and their caregivers) to help improve patients’ quality of life, as well as their longevity.

CCRAN's website: https://www.ccran.org/

CCRAN's Comprehensive Genomic Profiling(CGP) Reports: https://www.ccran.org/cgp-reports

If you have any questions or comments about this video, please contact us.

[Watch on YouTube]